BACKGROUND: Alcoholism is a progressive neurocognitive developmental disorder. Recent evidence shows that computerized training interventions (Cognitive Bias Modification, CBM) can reverse some of these maladaptively changed neurocognitive processes. A first clinical study of a CBM, called alcohol-avoidance training, found that trained alcoholic patients showed less relapse at one-year follow-up than control patients. The present study tested the replication of this result, and questions about mediation and moderation. METHODS:509 alcohol-dependent patients received treatment as usual (primarily Cognitive Behavior Therapy) inpatient treatment. Before and after treatment, the implicit approach bias was measured with the Alcohol Approach-Avoidance Task. Half of the patients were randomly assigned to CBM, the other half received treatment as usual only. Background variables, psychopathology and executive control were tested as possible moderating variables of CBM. One year after treatment, follow-up data about relapse were collected. RESULTS: The group receiving CBM developed alcohol-avoidance behavior and reported significantly lower relapse rates at one-year follow-up. Change in alcohol-approach bias mediated this effect. Moderation analyses demonstrated that older patients and patients with a strong approach-bias at pretest profited most from CBM. CONCLUSIONS:CBM is a promising treatment add-on in alcohol addiction and may counter some of the maladaptive neurocognitive effects of long-term alcoholism.
RCT Entities:
BACKGROUND: Alcoholism is a progressive neurocognitive developmental disorder. Recent evidence shows that computerized training interventions (Cognitive Bias Modification, CBM) can reverse some of these maladaptively changed neurocognitive processes. A first clinical study of a CBM, called alcohol-avoidance training, found that trained alcoholic patients showed less relapse at one-year follow-up than control patients. The present study tested the replication of this result, and questions about mediation and moderation. METHODS: 509 alcohol-dependent patients received treatment as usual (primarily Cognitive Behavior Therapy) inpatient treatment. Before and after treatment, the implicit approach bias was measured with the Alcohol Approach-Avoidance Task. Half of the patients were randomly assigned to CBM, the other half received treatment as usual only. Background variables, psychopathology and executive control were tested as possible moderating variables of CBM. One year after treatment, follow-up data about relapse were collected. RESULTS: The group receiving CBM developed alcohol-avoidance behavior and reported significantly lower relapse rates at one-year follow-up. Change in alcohol-approach bias mediated this effect. Moderation analyses demonstrated that older patients and patients with a strong approach-bias at pretest profited most from CBM. CONCLUSIONS: CBM is a promising treatment add-on in alcohol addiction and may counter some of the maladaptive neurocognitive effects of long-term alcoholism.
Authors: Tim M Schoenmakers; Marijn de Bruin; Irja F M Lux; Alexa G Goertz; Dorieke H A T Van Kerkhof; Reinout W Wiers Journal: Drug Alcohol Depend Date: 2010-01-12 Impact factor: 4.492
Authors: Hollis C Karoly; Joseph P Schacht; Joanna Jacobus; Lindsay R Meredith; Charles T Taylor; Susan F Tapert; Kevin M Gray; Lindsay M Squeglia Journal: Drug Alcohol Depend Date: 2019-05-14 Impact factor: 4.492
Authors: Jason M Sharbanee; Werner G K Stritzke; M Effin Jamalludin; Reinout W Wiers Journal: Psychopharmacology (Berl) Date: 2013-11-01 Impact factor: 4.530
Authors: Heiner Stuke; Stefan Gutwinski; Corinde E Wiers; Timo T Schmidt; Sonja Gröpper; Jenny Parnack; Christiane Gawron; Catherine Hindi Attar; Stephanie Spengler; Henrik Walter; Andreas Heinz; Felix Bermpohl Journal: J Psychiatry Neurosci Date: 2016-04 Impact factor: 6.186
Authors: Corinde E Wiers; Simone Kühn; Amir Homayoun Javadi; Ozlem Korucuoglu; Reinout W Wiers; Henrik Walter; Jürgen Gallinat; Felix Bermpohl Journal: Psychopharmacology (Berl) Date: 2013-04-19 Impact factor: 4.530
Authors: Adriaan Spruyt; Valentine Lemaigre; Bihiyga Salhi; Dinska Van Gucht; Helen Tibboel; Bram Van Bockstaele; Jan De Houwer; Jan Van Meerbeeck; Kristiaan Nackaerts Journal: Psychopharmacology (Berl) Date: 2015-03-13 Impact factor: 4.530
Authors: Jeanelle Portelli; Corinde E Wiers; Xiaobai Li; Sara L Deschaine; Gray R McDiarmid; Felix Bermpohl; Lorenzo Leggio Journal: Drug Alcohol Depend Date: 2019-09-11 Impact factor: 4.492